Bio-Rad Laboratories, Inc. Class A Common Stock vs Tidewater Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Tidewater Inc trades at $91 (market cap $4.54B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 2.1× Tidewater Inc's market cap. Which is the better fit depends on your goals.
| BIO | TDW | |
|---|---|---|
Market Cap | $9.43B | $4.54B |
Sector | Health | Utilities |
52-Week High | $356.25 | $91.20 |
52-Week Low | $241.71 | $47.29 |
Enterprise Value | $9.18B | $4.58B |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →